| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.675.448 | 5.771.888 | 5.867.515 | 5.751.402 | 5.766.012 | 6.159.407 | 5.954.313 | 6.328.755 | 6.816.994 | 7.185.698 |
| Total Income - EUR | 6.888.037 | 5.802.474 | 5.906.842 | 5.816.315 | 5.828.536 | 6.209.787 | 5.992.004 | 6.342.541 | 6.915.505 | 7.219.578 |
| Total Expenses - EUR | 6.850.195 | 5.689.600 | 5.749.981 | 5.717.726 | 5.720.110 | 6.032.787 | 5.848.525 | 6.263.530 | 6.767.640 | 7.210.084 |
| Gross Profit/Loss - EUR | 37.842 | 112.874 | 156.860 | 98.589 | 108.426 | 177.000 | 143.478 | 79.011 | 147.865 | 9.494 |
| Net Profit/Loss - EUR | 23.692 | 88.413 | 125.934 | 81.989 | 91.130 | 149.152 | 120.329 | 64.452 | 123.990 | 5.286 |
| Employees | 147 | 114 | 114 | 118 | 114 | 108 | 104 | 100 | 101 | 96 |
Check the financial reports for the company - Societatea Farmaceutica Arcatim S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.630.185 | 2.723.377 | 2.436.388 | 2.372.503 | 2.290.457 | 2.199.621 | 2.110.687 | 2.068.893 | 2.004.343 | 1.927.616 |
| Current Assets | 2.813.801 | 2.096.918 | 2.109.319 | 2.142.054 | 1.906.421 | 2.199.052 | 2.251.317 | 2.259.150 | 2.357.362 | 2.307.037 |
| Inventories | 624.313 | 489.689 | 515.233 | 469.679 | 530.875 | 589.605 | 561.386 | 642.028 | 706.789 | 756.109 |
| Receivables | 721.328 | 305.197 | 718.815 | 863.497 | 704.295 | 885.154 | 856.265 | 989.009 | 986.526 | 946.091 |
| Cash | 114.003 | 511.062 | 313.938 | 248.814 | 263.625 | 299.336 | 419.446 | 320.556 | 461.885 | 504.320 |
| Shareholders Funds | 3.821.259 | 3.871.865 | 3.817.963 | 3.706.456 | 3.645.404 | 3.636.046 | 3.529.898 | 3.484.599 | 3.533.766 | 3.396.005 |
| Social Capital | 408.937 | 404.766 | 398.899 | 391.578 | 383.995 | 376.715 | 368.361 | 369.504 | 368.384 | 366.325 |
| Debts | 1.639.519 | 957.369 | 731.828 | 824.636 | 554.573 | 772.260 | 837.350 | 855.052 | 843.556 | 865.556 |
| Income in Advance | 0 | 504 | 920 | 2.063 | 2.428 | 2.382 | 2.329 | 4.180 | 2.066 | 1.224 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Societatea Farmaceutica Arcatim S.a.